Daniel Peterson: Difference between revisions
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Notjusttired (talk | contribs) m (Text replacement - " \|" to " |") |
Notjusttired (talk | contribs) m (Text replacement - "author-link8 = | last8" to "author-link7 = | last8") |
||
| (268 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
[[File:Daniel Peterson.png|200px|thumb|right]] | [[File:Daniel Peterson.png|200px|thumb|right]] | ||
'''Daniel L. Peterson''', MD, is a physician in Incline Village, Nevada specializing in [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]] (ME/CFS). He was at the epicenter of the [[1984 Incline Village chronic fatigue syndrome outbreak]]<ref>{{Cite news|url=http://www.cortjohnson.org/chronic-fatigue-syndrome-mecfs-doctor-resource-center/dr-dan-peterson-sierra-internal-medicine-incline-village-nevada/|title=Dr. Dan Peterson (Sierra Internal Medicine, Incline Village, Nevada) - Health Rising|work=Health Rising|access-date=2018-08-13|language=en-US}}</ref> and continues to be a leader in treatment and research about [[ME/CFS]], serving on [[Simmaron Research]]’s Scientific Advisory Board and the Faculty of Health Sciences and Medicine at [[Griffith University]] in Queensland, Australia.<ref>{{Cite news|url=http://simmaronresearch.com/collaborative-research/|title=Collaborators - Simmaron Research|work=Simmaron Research|access-date=2018-08-13|language=en-US}}</ref> | '''Daniel L. Peterson''', MD, is a physician in Incline Village, Nevada specializing in [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]] (ME/CFS). He was at the epicenter of the [[1984 Incline Village chronic fatigue syndrome outbreak]]<ref>{{Cite news |url =http://www.cortjohnson.org/chronic-fatigue-syndrome-mecfs-doctor-resource-center/dr-dan-peterson-sierra-internal-medicine-incline-village-nevada/ | title = Dr. Dan Peterson (Sierra Internal Medicine, Incline Village, Nevada) - Health Rising|work=Health Rising|access-date=2018-08-13|language=en-US}}</ref> and continues to be a leader in treatment and research about [[ME/CFS]], serving on [[Simmaron Research]]’s Scientific Advisory Board and the Faculty of Health Sciences and Medicine at [[Griffith University]] in Queensland, Australia.<ref>{{Cite news |url =http://simmaronresearch.com/collaborative-research/ | title = Collaborators - Simmaron Research|work=Simmaron Research|access-date=2018-08-13|language=en-US}}</ref> | ||
He helped establish the Whittemore Peterson Institute (WPI) which was renamed in 2016 the [[Nevada Center for Biomedical Research]].<ref name="WPI">{{Cite web|website=[[Nevada Center for Biomedical Research]]|url=http://wpinstitute.org/about-page/ |title=About Us|access-date=2022-04-13}} </ref> He left in 2010 to return to private practice at Sierra Internal Medicine, Incline Village, Nevada.<ref name="trial-history">{{Cite web|url=https://clinicaltrials.gov/ct2/history/NCT00215813?V_5=View#StudyPageTop|date=2010-04-08|title=History of Changes for Study: NCT00215813 {{!}} Study of Ampligen in Chronic Fatigue Syndrome|website= ClinicalTrials.gov|access-date=2020-04-13}}</ref> In 2019, he joined the scientific advisory board of the [[Open Medicine Foundation]].<ref name="OMF-profile">{{Cite web|url=https://www.omf.ngo/people/daniel-l-peterson-md/|title=Daniel L. Peterson, MD|website=Open Medicine Foundation|language=en-US|access-date=2019-04-01}}</ref> | He helped establish the Whittemore Peterson Institute (WPI) which was renamed in 2016 the [[Nevada Center for Biomedical Research]].<ref name="WPI">{{Cite web | website=[[Nevada Center for Biomedical Research]] | url = http://wpinstitute.org/about-page/ | title = About Us|access-date=2022-04-13}} </ref> He left in 2010 to return to private practice at Sierra Internal Medicine, Incline Village, Nevada.<ref name="trial-history">{{Cite web | url = https://clinicaltrials.gov/ct2/history/NCT00215813?V_5=View#StudyPageTop | date = 2010-04-08 | title = History of Changes for Study: NCT00215813 {{!}} Study of Ampligen in Chronic Fatigue Syndrome | website = ClinicalTrials.gov|access-date=2020-04-13}}</ref> In 2019, he joined the scientific advisory board of the [[Open Medicine Foundation]].<ref name="OMF-profile">{{Cite web | url = https://www.omf.ngo/people/daniel-l-peterson-md/ | title = Daniel L. Peterson, MD | website = Open Medicine Foundation|language=en-US|access-date=2019-04-01}}</ref> | ||
Dr. Peterson was the first physician to use [[Ampligen]], an immunomodulator made by [[AIM ImmunoTech]] (formerly Hemispherx Biopharma), in the treatment for ME/CFS, using it on [[Nancy Kaiser]], a very severe patient.<ref>{{Cite web|url=http://www.ncf-net.org/forum/fall-vol12-3-2.htm|title=TREATING THE DISEASE, NOT THE SYMPTOMS: NCF'S RESEARCH MOVES CFIDS/ME ONE STEP CLOSER TO NEOPLASTIC DISEASE PROCESS|website= | Dr. Peterson was the first physician to use [[Ampligen]], an immunomodulator made by [[AIM ImmunoTech]] (formerly Hemispherx Biopharma), in the treatment for ME/CFS, using it on [[Nancy Kaiser]], a very severe patient.<ref>{{Cite web | url = http://www.ncf-net.org/forum/fall-vol12-3-2.htm | title = TREATING THE DISEASE, NOT THE SYMPTOMS: NCF'S RESEARCH MOVES CFIDS/ME ONE STEP CLOSER TO NEOPLASTIC DISEASE PROCESS | website = ncf-net.org|access-date=2018-08-13}}</ref> He has participated in every Ampligen trial since, up to the AMP-511, open label, cost-recovery trial available today.<ref name="NCT00215813">{{Cite news |url =https://clinicaltrials.gov/ct2/show/NCT00215813 | title = Ampligen in Chronic Fatigue Syndrome | website = ClinicalTrials.gov|access-date=2018-08-13|language=en}}</ref> | ||
Several documentaries about [[myalgic encephalomyelitis]]/[[chronic fatigue syndrome]] ([[ME/CFS]]) have featured Dr. Peterson, including, [[I Remember Me|''I'' ''Remember Me'']] and [[Forgotten Plague|''Forgotten Plague'']], and the news feature, [[Sick and Tired - Incline Village Outbreak|''Sick and Tired'']]. | Several documentaries about [[myalgic encephalomyelitis]]/[[chronic fatigue syndrome]] ([[ME/CFS]]) have featured Dr. Peterson, including, [[I Remember Me|''I'' ''Remember Me'']] and [[Forgotten Plague|''Forgotten Plague'']], and the news feature, [[Sick and Tired - Incline Village Outbreak|''Sick and Tired'']]. | ||
==Awards== | ==Awards== | ||
*2003, Rudy Perpich Senior Lectureship Award, presented to a distinguished CFS/FM scientist, physician or healthcare worker awarded by [[IACFS/ME]]<ref name=":0">{{Cite web|url=https://www.iacfsme.org/iacfs-me-awardees|title=IACFS/ME Awardees|website= | *2003, Rudy Perpich Senior Lectureship Award, presented to a distinguished CFS/FM scientist, physician or healthcare worker awarded by [[IACFS/ME]]<ref name=":0">{{Cite web | url = https://www.iacfsme.org/iacfs-me-awardees | title = IACFS/ME Awardees | website = | ||
IACFS/ME|access-date=2020-04-23}}</ref> | IACFS/ME|access-date=2020-04-23}}</ref> | ||
*2007, Nelson Gantz Outstanding Clinician Award awarded to a physician who emulates Nelson Gantz's clinical acumen, his passion for medicine, and his empathy for persons with CFS/FM awarded by [[IACFS/ME]]<ref name=":0" /> | *2007, Nelson Gantz Outstanding Clinician Award awarded to a physician who emulates Nelson Gantz's clinical acumen, his passion for medicine, and his empathy for persons with CFS/FM awarded by [[IACFS/ME]]<ref name=":0" /> | ||
== Writing committees == | == Writing committees == | ||
* 2003, [[Canadian Consensus Criteria]] - [[Myalgic encephalomyelitis|Myalgic Encephalomyelitis]]/[[Chronic fatigue syndrome|Chronic Fatigue Syndrome]]: Clinical Working Case Definition, Diagnostic and Treatment Protocols<ref>{{Cite journal|last=Carruthers|first=Bruce M.| | * 2003, [[Canadian Consensus Criteria]] - [[Myalgic encephalomyelitis|Myalgic Encephalomyelitis]]/[[Chronic fatigue syndrome|Chronic Fatigue Syndrome]]: Clinical Working Case Definition, Diagnostic and Treatment Protocols<ref>{{Cite journal | last = Carruthers | first = Bruce M. | authorlink = Bruce Carruthers | last2 = Jain | first2 = Anil Kumar | authorlink2 = Anil Kumar Jain | last3 = De Meirleir | first3 = Kenny L. | author-link3 = Kenny De Meirleir | last4 = Peterson | first4 = Daniel L. | author-link4 = Daniel Peterson | last5 = Klimas | first5 = Nancy G. | author-link5 = Nancy Klimas | last6 = Lerner | first6 = A. Martin | author-link6 = Martin Lerner | last7 = Bested | first7 = Alison C. | author-link7 = Alison Bested | last8 = Flor-Henry | first8 = Pierre | author-link8 = Pierre Flor-Henry | last9 = Joshi | first9 = Pradip | author-link9 = Pradip Joshi | last10 = Powles | first10 = AC Peter | author-link10 = A C Peter Powles | last11 = Sherkey | first11 = Jeffrey | author-link11 = Jeffrey Sherkey | last12 = van de Sande | first12 = Marjorie | author-link12 = Marjorie van de Sande | date = Jan 2003 | title = Myalgic Encephalomyelitis/Chronic Fatigue Syndrome | url =http://www.tandfonline.com/doi/full/10.1300/J092v11n01_02|journal=Journal of Chronic Fatigue Syndrome|language=en|volume=11|issue=1 | pages = 7–115|doi=10.1300/j092v11n01_02|issn=1057-3321|via=}}</ref> [http://phoenixrising.me/wp-content/uploads/Canadian-definition.pdf (Full Text)] | ||
* 2015, IOM Committee on Diagnostic Criteria for ME/CFS - Dr Peterson was a reviewer for the [[Institute of Medicine report|2015 report]] produced by the [[Institute of Medicine]]'s Committee on Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.<ref>https://www. | * 2015, IOM Committee on Diagnostic Criteria for ME/CFS - Dr Peterson was a reviewer for the [[Institute of Medicine report|2015 report]] produced by the [[Institute of Medicine]]'s Committee on Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.<ref name="SEID-IOM2015">{{Cite book | last=Institute of Medicine | authorlink = Institute of Medicine | title = Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness|location=Washington, DC|publisher=The National Academies Press | date = 2015 | url = https://www.ncbi.nlm.nih.gov/books/NBK284902/ | ||
|isbn=0309316898|pmid = 25695122|doi = 10.17226/19012 }}</ref> | |||
==Notable studies== | ==Notable studies== | ||
*1992, A chronic illness characterized by fatigue, neurologic and immunologic disorders, and active [[Human herpesvirus 6|human herpesvirus type 6]] infection<ref name="Buchwald, 1992" /> | *1992, A chronic illness characterized by fatigue, neurologic and immunologic disorders, and active [[Human herpesvirus 6|human herpesvirus type 6]] infection<ref name="Buchwald, 1992" /> [https://www.ncbi.nlm.nih.gov/pubmed/1309285 (Abstract)] | ||
*1992, Clinical, Epidemiologic, and Virologic Studies in Four Clusters of the [[Chronic Fatigue Syndrome]]<ref name="Levine, 1992" /> | *1992, Clinical, Epidemiologic, and Virologic Studies in Four Clusters of the [[Chronic Fatigue Syndrome]]<ref name="Levine, 1992" /> [https://www.researchgate.net/publication/21832955_Clinical_epidemiologic_and_virologic_studies_in_four_clusters_of_the_chronic_fatigue_syndrome (Abstract - can request full article)] | ||
*1995, Long Term Improvements in Patients with [[Chronic fatigue syndrome|Chronic Fatigue Syndrome]] Treated with [[Ampligen]]<ref name="Strayer,1995" /> [https://www.tandfonline.com/doi/abs/10.1300/j092v01n01_04 (Abstract)] | *1995, Long Term Improvements in Patients with [[Chronic fatigue syndrome|Chronic Fatigue Syndrome]] Treated with [[Ampligen]]<ref name="Strayer,1995" /> [https://www.tandfonline.com/doi/abs/10.1300/j092v01n01_04 (Abstract)] | ||
*1997, Editorial - [[Chronic Fatigue Syndrome]] and Disability<ref>{{Cite journal|last=Peterson|first=Daniel L.|date=Jan 1997|title=Chronic Fatigue Syndrome and Disability|url=http://www.tandfonline.com/doi/full/10.1300/J092v03n04_02|journal=Journal of Chronic Fatigue Syndrome|language=en|volume=3|issue=4|pages=5–7|doi=10.1300/j092v03n04_02|issn=1057-3321|via=}}</ref> [https://www.tandfonline.com/doi/abs/10.1300/J092v03n04_02 (Abstract)] | *1997, Editorial - [[Chronic Fatigue Syndrome]] and Disability<ref>{{Cite journal | last = Peterson | first = Daniel L. | date = Jan 1997 | title = Chronic Fatigue Syndrome and Disability | url = http://www.tandfonline.com/doi/full/10.1300/J092v03n04_02|journal=Journal of Chronic Fatigue Syndrome|language=en|volume=3|issue=4 | pages = 5–7|doi=10.1300/j092v03n04_02|issn=1057-3321|via=}}</ref> [https://www.tandfonline.com/doi/abs/10.1300/J092v03n04_02 (Abstract)] | ||
*2000, [[Chronic fatigue syndrome|Chronic Fatigue Syndrome]] and Cancer<ref name="Levine, 2000" /> [http://dx.doi.org/10.1300/J092v07n01_04 (Abstract)] | *2000, [[Chronic fatigue syndrome|Chronic Fatigue Syndrome]] and Cancer<ref name="Levine, 2000" /> [http://dx.doi.org/10.1300/J092v07n01_04 (Abstract)] | ||
*2001, Neuromyasthenia and [[Chronic Fatigue Syndrome]] (CFS) in Northern Nevada/California: A Ten-Year Follow-Up of an [[1984 Incline Village chronic fatigue syndrome outbreak|Outbreak]] <ref>{{Cite journal|last=Strickland|first=Paula S.|last2=Levine|first2=Paul H.|author-link2=Paul Levine|last3=Peterson|first3=Daniel L.|author-link3=Daniel Peterson|last4=O'Brien|first4=Karen|last5=Fears|first5=Thomas|date=Jan 2001|title=Neuromyasthenia and Chronic Fatigue Syndrome (CFS) in Northern Nevada/California|url=http://www.tandfonline.com/doi/full/10.1300/J092v09n03_02|journal=Journal of Chronic Fatigue Syndrome|language=en|volume=9|issue=3-4|pages=3–14|doi=10.1300/j092v09n03_02|issn=1057-3321|via=}}</ref> [[doi:10.1300/J092v09n03_02|(Abstract)]] | *2001, Neuromyasthenia and [[Chronic Fatigue Syndrome]] (CFS) in Northern Nevada/California: A Ten-Year Follow-Up of an [[1984 Incline Village chronic fatigue syndrome outbreak|Outbreak]]<ref>{{Cite journal | last = Strickland | first = Paula S. | last2 = Levine | first2 = Paul H. | author-link2 = Paul Levine | last3 = Peterson | first3 = Daniel L. | author-link3 = Daniel Peterson | last4 = O'Brien | first4 = Karen | last5 = Fears | first5 = Thomas | date = Jan 2001 | title = Neuromyasthenia and Chronic Fatigue Syndrome (CFS) in Northern Nevada/California | url = http://www.tandfonline.com/doi/full/10.1300/J092v09n03_02|journal=Journal of Chronic Fatigue Syndrome|language=en|volume=9|issue=3-4 | pages = 3–14 |doi=10.1300/j092v09n03_02|issn=1057-3321|via=}}</ref> [[doi:10.1300/J092v09n03_02|(Abstract)]] | ||
*2003, [[Myalgic encephalomyelitis|Myalgic Encephalomyelitis]]/[[Chronic fatigue syndrome|Chronic Fatigue Syndrome]]: Clinical Working Case Definition, Diagnostic and Treatment Protocols<ref>{{Cite journal|last=Carruthers|first=Bruce M.| | *2003, [[Myalgic encephalomyelitis|Myalgic Encephalomyelitis]]/[[Chronic fatigue syndrome|Chronic Fatigue Syndrome]]: Clinical Working Case Definition, Diagnostic and Treatment Protocols<ref>{{Cite journal | last = Carruthers | first = Bruce M. | authorlink = Bruce Carruthers | last2 = Jain | first2 = Anil Kumar | authorlink2 = Anil Kumar Jain | last3 = De Meirleir | first3 = Kenny L. | author-link3 = Kenny De Meirleir | last4 = Peterson | first4 = Daniel L. | author-link4 = Daniel Peterson | last5 = Klimas | first5 = Nancy G. | author-link5 = Nancy Klimas | last6 = Lerner | first6 = A. Martin | author-link6 = Martin Lerner | last7 = Bested | first7 = Alison C. | author-link7 = Alison Bested | last8 = Flor-Henry | first8 = Pierre | author-link8 = Pierre Flor-Henry | last9 = Joshi | first9 = Pradip | author-link9 = Pradip Joshi | last10 = Powles | first10 = AC Peter | author-link10 = A C Peter Powles | last11 = Sherkey | first11 = Jeffrey | author-link11 = Jeffrey Sherkey | last12 = van de Sande | first12 = Marjorie | author-link12 = Marjorie van de Sande | date = Jan 2003 | title = Myalgic Encephalomyelitis/Chronic Fatigue Syndrome | url =http://www.tandfonline.com/doi/full/10.1300/J092v11n01_02|journal=Journal of Chronic Fatigue Syndrome|language=en|volume=11|issue=1 | pages = 7–115|doi=10.1300/j092v11n01_02|issn=1057-3321|via=}}</ref> [http://phoenixrising.me/wp-content/uploads/Canadian-definition.pdf (Full Text)] | ||
*2004, Clinical and Biochemical Characteristics Differentiating Chronic Fatigue Syndrome from Major Depression and Healthy Control Populations: Relation to Dysfunction in the RNase L Pathway<ref>{{Cite journal|last=Suhadolnik|first=Robert J.| | *2004, Clinical and Biochemical Characteristics Differentiating Chronic Fatigue Syndrome from Major Depression and Healthy Control Populations: Relation to Dysfunction in the RNase L Pathway<ref>{{Cite journal | last = Suhadolnik | first = Robert J. | authorlink = Robert Suhadolnik | last2 = Peterson | first2 = Daniel L. | author-link2 = Daniel Peterson | last3 = Reichenbach | first3 = Nancy L. | author-link3 = | last4 = Roen | first4 = Gail | author-link4 = | last5 = Metzger | first5 = Melodie | author-link5 = | last6 = McCahan | first6 = John | last7 = O'Brien | first7 = Karen | last8 = Welsch | first8 = Suzanne | last9 = Gabriel | first9 = Jerome | last10 = Gaughan | first10 = John P. | last11 = McGregor | first11 = Neil R. | author-link11 = Neil McGregor | date = 2004 | title = Clinical and Biochemical Characteristics Differentiating Chronic Fatigue Syndrome from Major Depression and Healthy Control Populations: Relation to Dysfunction in the RNase L Pathway | url = https://www.tandfonline.com/doi/abs/10.1300/J092v12n01_02|journal=Journal of Chronic Fatigue Syndrome|volume=12|issue=1 | pages = 5-35|doi=10.1300/J092v12n01_02|quote=|via=|pmc=|pmid=|access-date=}}</ref> [https://www.researchgate.net/publication/249886680_Clinical_and_Biochemical_Characteristics_Differentiating_Chronic_Fatigue_Syndrome_from_Major_Depression_and_Healthy_Control_Populations (Full Text)] | ||
*2012, A Multicenter Blinded Analysis Indicates No Association between [[ME/CFS|Chronic Fatigue Syndrome/Myalgic Encephalomyelitis]] and either [[Xenotropic murine leukemia virus-related virus|Xenotropic Murine Leukemia Virus-Related Virus]] or Polytropic Murine Leukemia Virus<ref name="Alter, et al, 2012" /> [http://mbio.asm.org/content/3/5/e00266-12 (Abstract)] | *2012, A Multicenter Blinded Analysis Indicates No Association between [[ME/CFS|Chronic Fatigue Syndrome/Myalgic Encephalomyelitis]] and either [[Xenotropic murine leukemia virus-related virus|Xenotropic Murine Leukemia Virus-Related Virus]] or Polytropic Murine Leukemia Virus<ref name="Alter, et al, 2012" /> [http://mbio.asm.org/content/3/5/e00266-12 (Abstract)] | ||
*2012, A double-blind, placebo-controlled, randomized, clinical trial of the TLR-3 agonist [[Ampligen|rintatolimod]] in severe cases of [[chronic fatigue syndrome]]<ref name="Strayer, 2012" /> [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3448165/ (Full Text)] | *2012, A double-blind, placebo-controlled, randomized, clinical trial of the TLR-3 agonist [[Ampligen|rintatolimod]] in severe cases of [[chronic fatigue syndrome]]<ref name="Strayer, 2012" /> [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3448165/ (Full Text)] | ||
*2014, No association found between the detection of either [[xenotropic murine leukemia virus-related virus]] or polytropic murine leukemia virus and [[chronic fatigue syndrome]] in a blinded, multi-site, prospective study by the establishment and use of the [[SolveCFS BioBank & Patient Registry|SolveCFS BioBank]]<ref>{{Cite journal|last=Irlbeck|first=David M.|last2=Vernon|first2=Suzanne D.|author-link2=Suzanne Vernon|last3=McCleary|first3=K. Kimberly|author-link3=Kim McCleary|last4=Bateman|first4=Lucinda|author-link4=Lucinda Bateman|last5=Klimas|first5=Nancy G.|author-link5=Nancy Klimas|last6=Lapp|first6=Charles W.|author-link6=Charles Lapp|last7=Peterson|first7=Daniel L.|author-link7=Daniel Peterson|last8=Brown|first8=James R.|last9=Remlinger|first9=Katja S.|date=2014|title=No association found between the detection of either xenotropic murine leukemia virus-related virus or polytropic murine leukemia virus and chronic fatigue syndrome in a blinded, multi-site, prospective study by the establishment and use of the SolveCFS BioBank|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4236736/|journal=BMC Research Notes|volume=7|pages=461|doi=10.1186/1756-0500-7-461|via=|last10=Wilfret|last11=Gerondelis|first11=Peter|first10=David A.}}</ref> [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4236736/ (Full Text)] | *2014, No association found between the detection of either [[xenotropic murine leukemia virus-related virus]] or polytropic murine leukemia virus and [[chronic fatigue syndrome]] in a blinded, multi-site, prospective study by the establishment and use of the [[SolveCFS BioBank & Patient Registry|SolveCFS BioBank]]<ref>{{Cite journal | last = Irlbeck | first = David M. | last2 = Vernon | first2 = Suzanne D. | author-link2 = Suzanne Vernon | last3 = McCleary | first3 = K. Kimberly | author-link3 = Kim McCleary | last4 = Bateman | first4 = Lucinda | author-link4 = Lucinda Bateman | last5 = Klimas | first5 = Nancy G. | author-link5 = Nancy Klimas | last6 = Lapp | first6 = Charles W. | author-link6 = Charles Lapp | last7 = Peterson | first7 = Daniel L. | author-link7 = Daniel Peterson | last8 = Brown | first8 = James R. | last9 = Remlinger | first9 = Katja S. | date = 2014 | title = No association found between the detection of either xenotropic murine leukemia virus-related virus or polytropic murine leukemia virus and chronic fatigue syndrome in a blinded, multi-site, prospective study by the establishment and use of the SolveCFS BioBank | url =https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4236736/|journal=BMC Research Notes|volume=7 | pages = 461|doi=10.1186/1756-0500-7-461|via= | last10 = Wilfret | last11 = Gerondelis | first11 = Peter | first10 = David A.}}</ref> [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4236736/ (Full Text)] | ||
*2015, [[Cytokines]] in the Cerebrospinal Fluids of Patients with [[ME/CFS|Chronic Fatigue Syndrome/Myalgic Encephalomyelitis]]<ref name="Peterson, 2015" /> [https://www.hindawi.com/journals/mi/2015/929720/ (Full Text)] | *2015, [[Cytokines]] in the Cerebrospinal Fluids of Patients with [[ME/CFS|Chronic Fatigue Syndrome/Myalgic Encephalomyelitis]]<ref name="Peterson, 2015" /> [https://www.hindawi.com/journals/mi/2015/929720/ (Full Text)] | ||
*2015, Findings from a clinical and laboratory database developed for discovery of pathogenic mechanisms in myalgic encephalomyelitis/chronic fatigue syndrome<ref name="KlimasNG, 2015" /> [http://www.tandfonline.com/doi/full/10.1080/21641846.2015.1023652 (Abstract)] | *2015, Findings from a clinical and laboratory database developed for discovery of pathogenic mechanisms in myalgic encephalomyelitis/chronic fatigue syndrome<ref name="KlimasNG, 2015" /> [http://www.tandfonline.com/doi/full/10.1080/21641846.2015.1023652 (Abstract)] | ||
*2015, Chronic fatigue syndrome and co-morbid and consequent conditions: evidence from a multi-site clinical epidemiology study<ref name="BatemanL, 2015" /> [http://www.tandfonline.com/doi/full/10.1080/21641846.2014.978109 (Abstract)] | *2015, Chronic fatigue syndrome and co-morbid and consequent conditions: evidence from a multi-site clinical epidemiology study<ref name="BatemanL, 2015" /> [http://www.tandfonline.com/doi/full/10.1080/21641846.2014.978109 (Abstract)] | ||
* 2015, Distinct plasma immune signatures in ME/CFS are present early in the course of illness<ref>{{Cite journal|last1=Hornig|first1=M| | * 2015, Distinct plasma immune signatures in ME/CFS are present early in the course of illness<ref>{{Cite journal | last1 = Hornig | first1 = M | authorlink = Mady Hornig | last2 = Montoya | first2 = JG | authorlink2 = Jose Montoya | last3 = Klimas | first3 = NG | author-link3 = Nancy Klimas | last4 = Levine | first4 = SM | author-link4 = Susan Levine | last5 = Felsenstein | first5 = D | author-link5 = Donna Felsenstein | last6 = Bateman | first6 = L | author-link6 = Lucinda Bateman | last7 = Peterson | first7 = DL | author-link8 = Daniel Peterson | last8 = Gottschalk | first8 = CG | author-link8 = Gunnar Gottschalk | last9 = Schultz | first9 = AF | author-link9 = Andrew Schultz | last10 = Che | first10 = X | author-link10 = Xiaoyu Che | last11 = Eddy | first11 = ML | author-link11 = Meredith Eddy | last12 = Komaroff | first12 = AL | author-link12 = Anthony Komaroff | last13 = Lipkin | first13 = WI | author-link13 = Ian Lipkin | title = Distinct plasma immune signatures in ME/CFS are present early in the course of illness|journal=Science Advances|volume=1|issue=1| page = | date = 2015 | pmid = |doi =10.1126/sciadv.1400121 | url = http://advances.sciencemag.org/content/1/1/e1400121.full}}</ref> - [https://advances.sciencemag.org/content/1/1/e1400121 (Full text)] | ||
*2016, [[Cytokine]] network analysis of cerebrospinal fluid in | *2016, [[Cytokine]] network analysis of cerebrospinal fluid in myalgic encephalomyelitis/chronic fatigue syndrome<ref name="Hornig, 2016" /> [https://www.nature.com/articles/mp201529 (Abstract)] | ||
*2017, Fecal metagenomic profiles in subgroups of patients with | *2017, Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome<ref name="Nagy-Szakal, 2017" /> [https://microbiomejournal.biomedcentral.com/articles/10.1186/s40168-017-0261-y (Full Text)] | ||
*2017, Multi-Site Clinical Assessment of | *2017, Multi-Site Clinical Assessment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (MCAM): Design and Implementation of a Prospective/Retrospective Rolling Cohort Study<ref name="Unger, 2017" /> [https://academic.oup.com/aje/article/185/8/617/3073694 (Full Text)] | ||
*2017, Immune network analysis of cerebrospinal fluid in | *2017, Immune network analysis of cerebrospinal fluid in myalgic encephalomyelitis/chronic fatigue syndrome with atypical and classical presentations<ref name="Hornig, 2017" /> [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5416687/ (Full Text)] | ||
*2018, Decreased Expression of [[TRPM3]] and [[mAChRM3]] in the Small Intestine in [[ME/CFS|Chronic Fatigue Syndrome/Myalgic Encephalomyelitis]]<ref>{{Cite journal|last=Marshall-Gradisnik|first=Sonya| | *2018, Decreased Expression of [[TRPM3]] and [[mAChRM3]] in the Small Intestine in [[ME/CFS|Chronic Fatigue Syndrome/Myalgic Encephalomyelitis]]<ref name="Gradisnik2018">{{Cite journal | last = Marshall-Gradisnik | first = Sonya | authorlink = Sonya Marshall-Gradisnik | last2 = Fretel | first2 = Marshall | authorlink2 = | last3 = Eaton | first3 = Natalie | author-link3 = | last4 = Cabanas | first4 = Helene | author-link4 = Hélène Cabanas | last5 = Balinas | first5 = Cassandra | author-link5 = | last6 = Gopalan | first6 = Vinod | last7 = Petersen | first7 = Daniel | author-link8 = Daniel Peterson | last8 = Passmore | first8 = Rachel | last9 = Tang | first9 = Kevin | last10 = Haque | first10 = Mazhar | author-link10 = | last11 = Lam | first11 = Alfred | author-link11 = | last12 = Staines | first12 = Donald | author-link12 = Donald Staines | date = 2018-05-31 | title = Decreased Expression of TRPM3 and mAChRM3 in the Small Intestine in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis |url =http://www.scirp.org/journal/PaperInformation.aspx?PaperID=85005&#abstract|journal=International Journal of Clinical Medicine|language=en|volume=09|issue=05 | pages = 467|doi=10.4236/ijcm.2018.95040|via=|pmc=|pmid=|quote= |access-date= }}</ref> [http://file.scirp.org/Html/11-2101759_85005.htm (Full text)] | ||
*2018, Insights into | *2018, Insights into myalgic encephalomyelitis/chronic fatigue syndrome phenotypes through comprehensive [[metabolomics]]<ref name="Nagy-Szakal, 2018" /> [https://www.nature.com/articles/s41598-018-28477-9.pdf (Full Text)] | ||
*2020, Myalgic encephalomyelitis/chronic fatigue syndrome patients exhibit altered T cell metabolism and cytokine associations<ref name="Mandarano2020">{{Cite journal|last=Mandarano|first=Alexandra H.| | *2020, Myalgic encephalomyelitis/chronic fatigue syndrome patients exhibit altered T cell metabolism and cytokine associations<ref name="Mandarano2020">{{Cite journal | last = Mandarano | first = Alexandra H. | authorlink = | last2 = Maya | first2 = Jessica | authorlink2 = | last3 = Giloteaux | first3 = Ludovic | author-link3 = | last4 = Peterson | first4 = Daniel L. | author-link4 = Daniel Peterson | last5 = Maynard | first5 = Marco | author-link5 = | last6 = Gottschalk | first6 = C. Gunnar | author-link6 = Gunnar Gottschalk | last7 = Hanson | first7 = Maureen R. | last8 = Maureen Hanson | first8 = | date = 2020-02-10 | title = Myalgic encephalomyelitis/chronic fatigue syndrome patients exhibit altered T cell metabolism and cytokine associations |url =https://www.jci.org/articles/view/132185|journal=Journal of Clinical Investigation|language=en|volume=130|issue=3 | pages = 1491-1505|doi=10.1172/jci132185|pmc=|pmid=|access-date=|quote=|via=}}</ref> - [https://www.jci.org/articles/view/132185 (Full text)] | ||
* 2021, Molecular evidence of autophagy impairment as serum level of ATG13 is elevated in patients with myalgic encephalomyelitis and chronic fatigue syndrome: two independent case-control studies<ref name="Roy2021">{{Cite web | url = https://www.researchsquare.com/ | title = Molecular evidence of autophagy impairment as serum level of ATG13 is elevated in patients with myalgic encephalomyelitis and chronic fatigue syndrome: two independent case-control studies | last = Avik | first = R | authorlink = Avik Roy | last2 = Gottschalk | first2 = Carl G | authorlink2 = Gunnar Gottschalk | last3 = Peterson | first3 = Daniel | author-link3 = Daniel Peterson | last4 = Knox | first4 = K | author-link4 = | last5 = Maynard | first5 = M | author-link5 = | last6 = Whelan | first6 = RJ | author-link6 = | date = 2021-09-29 | website = Researchsquare | doi = 10.21203/rs.3.rs-925403/v1| url-status= |access-date=2022-11-05 }}</ref> - [https://www.researchgate.net/publication/354943608_Molecular_evidence_of_autophagy_impairment_as_serum_level_of_ATG13_is_elevated_in_patients_with_myalgic_encephalomyelitis_and_chronic_fatigue_syndrome_two_independent_case-control_studies (Pre-print, Full text)] | |||
* 2022, Elevated ATG13 in serum of patients with ME/CFS stimulates oxidative stress response in microglial cells via activation of receptor for advanced glycation end products (RAGE)<ref name="Roy2022">{{Cite journal | title = Elevated ATG13 in serum of patients with ME/CFS stimulates oxidative stress response in microglial cells via activation of receptor for advanced glycation end products (RAGE) | date = 2022-05-01 | url = https://www.sciencedirect.com/science/article/pii/S1044743122000379|journal=Molecular and Cellular Neuroscience |volume=120 |issue= | page = 103731 | last = Gottschalk | first = Carl G | authorlink = Gunnar Gottschalk | last2 = Peterson | first2 = Daniel | authorlink2 = Daniel Peterson | last3 = Knox | first3 = Konstance | author-link3 = | last4 = Maynard | first4 = Marco | author-link4 = | last5 = Whelan | first5 = Ryan J. | author-link5 = | last6 = Roy | first6 = Avik | author-link6 = Roy Avik |doi=10.1016/j.mcn.2022.103731|pmc=|pmid= |issn=1044-7431|quote=|via=}}</ref> - [https://www.sciencedirect.com/science/article/abs/pii/S1044743122000379 (Abstract)] | |||
==Talks and interviews== | ==Talks and interviews== | ||
| Line 51: | Line 54: | ||
*2007, Speaker on Day 1 of the 2nd [[Invest in ME International ME Conference]] on ''Experiences of Research into ME/CFS: Past, Present, and Future'' - [https://www.youtube.com/watch?v=PJ_x7hChxWk (Video)] | *2007, Speaker on Day 1 of the 2nd [[Invest in ME International ME Conference]] on ''Experiences of Research into ME/CFS: Past, Present, and Future'' - [https://www.youtube.com/watch?v=PJ_x7hChxWk (Video)] | ||
*2007, Speaker on Day 2 of the 2nd [[Invest in ME International ME Conference]] on ''Clinical Research -'' [https://www.youtube.com/watch?v=ONqaODDtbeQ (Video)] | *2007, Speaker on Day 2 of the 2nd [[Invest in ME International ME Conference]] on ''Clinical Research -'' [https://www.youtube.com/watch?v=ONqaODDtbeQ (Video)] | ||
*2009, Speaker at the 4th [[Invest in ME International ME Conference]] on ''Treatment Regimes for the Most Severe Cases''<ref>{{Cite web|url=http://www.investinme.org/IIMEC4.shtml#agenda|title= | *2009, Speaker at the 4th [[Invest in ME International ME Conference]] on ''Treatment Regimes for the Most Severe Cases''<ref>{{Cite web | url = http://www.investinme.org/IIMEC4.shtml#agenda | title = IIMEC4 | website = [[Invest in ME Research]]|access-date=2020-02-04}}</ref> [http://www.investinme.org/IIMEC4.shtml#dvd DVD available] | ||
*2012, Speaker at the 7th [[Invest in ME International ME Conference]] on ''Clinical Research Update 2012''<ref>{{Cite web|url=http://www.investinme.org/IIMEC7.shtml#agenda|title= | *2012, Speaker at the 7th [[Invest in ME International ME Conference]] on ''Clinical Research Update 2012''<ref>{{Cite web | url = http://www.investinme.org/IIMEC7.shtml#agenda | title = IIMEC7 International ME Conference 2012 | website = [[Invest in ME Research]]|access-date=2020-02-04}}</ref> [http://www.investinme.org/IIMEC7.shtml#dvd DVD available] | ||
*2013, Speaker at the 8th [[Invest in ME International ME Conference]] on ''Key Note Speech: The Mainstreaming of ME Research''<ref>{{Cite web|url=http://www.investinme.org/IIMEC8.shtml#agenda|title= | *2013, Speaker at the 8th [[Invest in ME International ME Conference]] on ''Key Note Speech: The Mainstreaming of ME Research''<ref>{{Cite web | url = http://www.investinme.org/IIMEC8.shtml#agenda | title = IIMEC8 International ME Conference 2013 | website = [[Invest in ME Research]]|access-date=2020-02-04}}</ref> [http://www.investinme.org/IIMEC8.shtml#dvd DVD available] | ||
===Other=== | ===Other=== | ||
*1996, ''Primetime Live'' TV Show - [[Sick and Tired - Incline Village Outbreak]]<ref>{{Citation|title=CFS and the CDC's Failure to Respond: Primetime Live (1996)|url=https://www.youtube.com/watch?v=AW0x9_Q8qbo|language=en|access-date=2020-02-04}}</ref> | *1996, ''Primetime Live'' TV Show - [[Sick and Tired - Incline Village Outbreak]]<ref>{{Citation | title = CFS and the CDC's Failure to Respond: Primetime Live (1996) | url = https://www.youtube.com/watch?v=AW0x9_Q8qbo|language=en|access-date=2020-02-04}}</ref> | ||
*2000 Documentary, ''[[I Remember Me]],'' directed by Kim A. Snyder<ref>{{Citation|title=I Remember Me|url=http://www.imdb.com/title/tt0293270/|access-date=2020-02-04}}</ref> | *2000 Documentary, ''[[I Remember Me]],'' directed by Kim A. Snyder<ref>{{Citation | title = I Remember Me | url =http://www.imdb.com/title/tt0293270/|access-date=2020-02-04}}</ref> | ||
*2011, [https://www.youtube.com/watch?v=d86dNggUVRI Dr. med. Dan Peterson (Simmaron Research) - Diagnose und Behandlung von ME/CFS, Teil 2] | *2011, [https://www.youtube.com/watch?v=d86dNggUVRI Dr. med. Dan Peterson (Simmaron Research) - Diagnose und Behandlung von ME/CFS, Teil 2] | ||
*2011, [https://www.youtube.com/watch?v=pyHo9-ShkXI Dr. med. Dan Peterson (Simmaron Research) - Diagnose und Behandlung von ME/CFS, Teil 1] | *2011, [https://www.youtube.com/watch?v=pyHo9-ShkXI Dr. med. Dan Peterson (Simmaron Research) - Diagnose und Behandlung von ME/CFS, Teil 1] | ||
| Line 83: | Line 86: | ||
==References== | ==References== | ||
<references> | <references> | ||
<ref name="Alter, et al, 2012">{{Citation | <ref name="Alter, et al, 2012">{{Citation | last1 = Alter | first1 = Harvey J. | author-link1 = | last2 =Mikovits | first2 = Judy A. | authorlink2 = Judy Mikovits | last3 = Switzer | first3 = William M. | author-link3 = | last4 =Ruscetti | first4 = Francis W. | author-link4 = | last5 = Lo | first5 = Shyh-Ching | author-link5 = | last6 = Klimas | first6 = Nancy | author-link6 = Nancy Klimas | last7 = Komaroff | first7 = Anthony L. | author-link8 = Anthony Komaroff | last8 = Montoya | first8 = Jose G. | author-link8 = Jose Montoya | last9 = Bateman | first9 = Lucinda| author-link9 = Lucinda Bateman | last10 = Levine | first10 = Susan | author-link10 = Susan Levine | last11 = Peterson | first11 = Daniel | author-link11 = Daniel Peterson | last12 = Levin | first12 = Bruce | author-link12 = Bruce Levin | last13 = Hanson | first13 = Maureen R. | author-link13 = Maureen Hanson | last14 = Genfi | first14 = Afia | author-link14 = | last15 = Bhat | first15 = Meera | author-link15 = | last16 = Zheng | first16 = HaoQiang | author-link16 = | last17 = Wang | first17 = Richard | author-link17 = | last18 = Li | first18 = Bingjie | author-link18 = | last19 = Hung | first19 = Guo-Chiuan | author-link19 = | last20 = Lee | first20 = Li Ling | authorlink20 = | last21 = Sameroff | first21 = Stephen | authorlink21 = | last22 = Heneine | first22 = Walid | authorlink22 = | last23 = Coffin | first23 = John | authorlink23 = | last24 = Hornig | first24 = Mady | authorlink24 = Mady Hornig | last25 = Lipkin | first25 = W. Ian | authorlink25 = Ian Lipkin | title = A Multicenter Blinded Analysis Indicates No Association between Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and either Xenotropic Murine Leukemia Virus-Related Virus or Polytropic Murine Leukemia Virus | journal = mBio | volume = 3 | issue = 5 | page = e00266–12 | date = 2012 | pmid = | doi = 10.1128/mBio.00266-12 }}</ref> | ||
| last1 | <ref name="BatemanL, 2015">{{Citation | last1 = Bateman | first1 = L. | author-link1 = Lucinda Bateman | last2 =Darakjy | first2 = S. | authorlink2 = | last3 = Klimas | first3 = N. | author-link3 = Nancy Klimas | last4 =Peterson | first4 = D. | author-link4 = Daniel Peterson | last5 = Levine | first5 = S.M. | author-link5 = Susan Levine | last6 = Allen | first6 = A. | author-link6 = | last7 = Carlson | first7 = S.A. | author-link7 = | last8 = Balbin | first8 = E.G. | author-link8 = Elizabeth Balbin | last9 = Gottschalk | first9 = G. | author-link9 = Gunnar Gottschalk | last10 = March | first10 = D. | author-link10 = | title = Chronic fatigue syndrome and co-morbid and consequent conditions: evidence from a multi-site clinical epidemiology study | journal = Fatigue: Biomedicine, Health & Behavior | volume = 3 | issue = 1 | page = 1-15 | date = 2015 | pmid = | doi = 10.1080/21641846.2014.978109 }}</ref> | ||
| last2 | <ref name="Buchwald, 1992">{{Citation | last1 = Buchwald | first1 = Dedra | author-link1 = Dedra Buchwald | last2 =Cheney | first2 = Paul R. | authorlink2 = Paul Cheney | last3 =Peterson | first3 = Daniel L. | author-link3 = Daniel Peterson | last4 =Henry | first4 = Berch | author-link4 = | last5 = Wormsley | first5 = Susan B. | author-link5 = | last6 = Geiger | first6 = Ann | author-link6 = | last7 =Ablashi | first7 = Dharam V. | author-link8 = Dharam Ablashi | last8 = Salahuddin | first8 = S. Zaki | author-link8 = | last9 = Saxinger | first9 = Carl | author-link9 = | last10 = Biddle | first10 = Royce | author-link10 = | last11 = Kikinis | first11 = Ron | author-link11 = | last12 = Jolesz | first12 = Ferenc A. | author-link12 = | last13 = Folks | first13 = Thomas | author-link13 = | last14 = Balachandran | first14 = N. | author-link14 = | last15 = Peter | first15 = James B. | author-link15 = | last16 = Gallo | first16 = Robert C. | author-link16 = | last17 = Komaroff | first17 = Anthony L. | author-link17 = Anthony Komaroff | title = A chronic illness characterized by fatigue, neurologic and immunologic disorders, and active human herpesvirus type 6 infection | journal = Annals of Internal Medicine | volume = 116 | issue = 2 | page = 103-113 | date = 1992 | pmid = 1309285 }}</ref> | ||
| last3 | <ref name="Hornig, 2016">{{Citation | last1 = Hornig | first1 = M | author-link1 = Mady Hornig | last2 = Gottschalk | first2 = G | authorlink2 = Gunnar Gottschalk | last3 =Peterson | first3 = D | author-link3 = Daniel Peterson | last4 = Knox | first4 = KK | author-link4 = | last5 = Schultz | first5 = AF | author-link5 = | last6 = Eddy | first6 = ML | author-link6 = | last7 = Che | first7 = X | author-link7 = | last8 = Lipkin | first8 = WI | author-link8 = Ian Lipkin | title = Cytokine network analysis of cerebrospinal fluid in myalgic encephalomyelitis/chronic fatigue syndrome. | journal = Molecular Psychiatry | volume = 21 | issue = 2 | page = 261-9 | date = 2016 | doi = 10.1038/mp.2015.29 }}</ref> | ||
| last4 | <ref name="Hornig, 2017">{{Citation | last1 = Hornig | first1 = M | author-link1 = Mady Hornig | last2 = Gottschalk | first2 = G | authorlink2 = Gunnar Gottschalk | last3 =Eddy | first3 = ML | author-link3 = | last4 =Che | first4 = X | author-link4 = | last5 = Ukaigwe | first5 = JE | author-link5 = | last6 = Peterson | first6 = DL | author-link6 = Daniel Peterson | last7 =Lipkin | first7 = WI | author-link8 = Ian Lipkin | title = Immune network analysis of cerebrospinal fluid in myalgic encephalomyelitis/chronic fatigue syndrome with atypical and classical presentations | journal = Translational Psychiatry | volume = 7 | issue = 4 | page = | date = 2017 | doi = 10.1038/tp.2017.44 }}</ref> | ||
| last5 | <ref name="KlimasNG, 2015">{{Citation | last1 = Klimas | first1 = N.G. | author-link1 = Nancy Klimas | last2 =Ironson | first2 = G. | authorlink2 = | last3 =Carter | first3 = A. | author-link3 = | last4 =Balbin | first4 = E. | author-link4 = Elizabeth Balbin | last5 = Bateman | first5 = L. | author-link5 = Lucinda Bateman | last6 = Felsenstein | first6 = D. | author-link6 = Donna Felsenstein | last7 =Levine | first7 = S. | author-link8 = Susan Levine | last8 = Peterson | first8 = D. | author-link8 = Daniel Peterson | last9 = Chiu | first9 = K. | author-link9 = | last10 = Allen | first10 = A. | author-link10 = | last11 = Cunningham | first11 = K. | author-link11 = | last12 = Gottschalk | first12 = C.G. | author-link12 = Gunnar Gottschalk | last13 = Fletcher | first13 = M | author-link13 = Mary Ann Fletcher | last14 = Hornig | first14 = M. | author-link14 = Mady Hornig | last15 = Canning | first15 = C. | author-link15 = | last16 = Komaroff | first16 = A.L. | author-link16 = Anthony Komaroff | title = Findings from a clinical and laboratory database developed for discovery of pathogenic mechanisms in myalgic encephalomyelitis/chronic fatigue syndrome | journal = Fatigue: Biomedicine, Health & Behavior | volume = 3 | issue = 2| page = 75-96 | date = 2015 | pmid = | doi = 10.1080/21641846.2015.1023652 }}</ref> | ||
| last6 | <ref name="Levine, 1992">{{Citation | last1 = Levine | first1 = Paul H. | author-link1 = Paul Levine | last2 = Jacobson | first2 = Steven | authorlink2 = | last3 =Pocinki | first3 = Alan G. | author-link3 = Alan Pocinki | last4 =Cheney | first4 = Paul | author-link4 = Paul Cheney | last5 = Peterson | first5 = Daniel | author-link5 = Daniel Peterson | last6 = Connelly | first6 = Roger R | author-link6 = | last7 =Weil | first7 = R | author-link7 = | last8 = Robinson | first8 = SM | author-link8 = | last9 = Ablashi | first9 = Dharam V | author-link9 = Dharam Ablashi | last10 = Salahuddin | first10 = Sayeef Z | author-link10 = | last11 = Pearson | first11 = GR | author-link11 = | last12 = Hoover | first12 = R | author-link12 = | title = Clinical, Epidemiologic, and Virologic Studies in Four Clusters of the Chronic Fatigue Syndrome | journal = Archives of Internal Medicine | volume = 152 | issue = 8 | page = 1611-1616 | date = 1992 | pmid = | doi = 10.1001/archinte.1992.00400200049009 }}</ref> | ||
| last7 | <ref name="Levine, 2000">{{Citation | last1 = Levine | first1 = Paul H. | author-link1 = Paul Levine | last2 =Pilkington | first2 = Deborah | authorlink2 = | last3 = Strickland | first3 = Paula | author-link3 = | last4 =Peterson | first4 = Daniel | author-link4 = Daniel Peterson | title = Chronic Fatigue Syndrome and Cancer | journal = Journal of Chronic Fatigue Syndrome | volume = 7 | issue = 1 | page = 29-38 | date = 2000 | pmid = | doi = 10.1300/J092v07n01_04 }}</ref> | ||
| last8 | <ref name="Nagy-Szakal, 2017">{{Citation | last1 = Nagy-Szakal | first1 = Dorottya | author-link1 = Dorottya Nagy-Szakal | last2 =Williams | first2 = Brent L. | authorlink2 = | last3 =Mishra | first3 = Nischay | author-link3 = | last4 =Che | first4 = Xiaoyu| author-link4 = | last5 = Lee | first5 = Bohyun | author-link5 = | last6 = Bateman | first6 = Lucinda | author-link6 = Lucinda Bateman | last7 = Klimas | first7 = Nancy G. | author-link8 = Nancy Klimas | last8 = Komaroff | first8 = Anthony L. | author-link8 = Anthony Komaroff | last9 = Levine | first9 = Susan | author-link9 = Susan Levine | last10 = Montoya | first10 = Jose G. | author-link10 = Jose Montoya | last11 = Peterson | first11 = Daniel L. | author-link11 = Daniel Peterson | last12 = Ramanan | first12 = Devi | author-link12 = | last13 = Jain | first13 = Komal | author-link13 = | last14 = Eddy | first14 = Meredith L. | author-link14 = | last15 = Hornig | first15 = Mady | author-link15 = Mady Hornig | last16 = Lipkin | first16 = W. Ian | author-link16 = Ian Lipkin | title = Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome | journal = Microbiome | volume = 5 | issue = 44 | page = | date = 2017 | pmid = | doi = 10.1186/s40168-017-0261-y }}</ref> | ||
| last9 | <ref name="Nagy-Szakal, 2018">{{Citation | last1 = Nagy-Szakal | first1 = Dorottya | author-link1 = Dorottya Nagy-Szakal | last2 =Barupal | first2 = Dinesh K. | authorlink2 = | last3 =Lee | first3 = Bohyun | author-link3 = | last4 =Che | first4 = Xiaoyu| author-link4 = | last5 = Williams | first5 = Brent L. | author-link5 = | last6 = Kahn | first6 = Ellie J.R. | author-link6 = | last7 =Ukaigwe | first7 = Joy E. | author-link7 = | last8 = Bateman | first8 = Lucinda | author-link8 = Lucinda Bateman | last9 = Klimas | first9 = Nancy G. | author-link9 = Nancy Klimas | last10 = Komaroff | first10 = Anthony L. | author-link10 = Anthony Komaroff | last11 = Levine | first11 = Susan | author-link11 = Susan Levine | last12 = Montoya | first12 = Jose G. | author-link12 = Jose Montoya | last13 = Peterson | first13 = Daniel L. | author-link13 = Daniel Peterson | last14 = Levin | first14 = Bruce| author-link14 = Bruce Levin | last15 = Hornig | first15 = Mady | author-link15 = Mady Hornig | last16 = Fiehn | first16 = Oliver | author-link16 = | last17 = Lipkin | first17 = W. Ian | author-link17 = Ian Lipkin | title = Insights into myalgic encephalomyelitis/chronic fatigue syndrome phenotypes through comprehensive metabolomics | journal = Scientific Reports | volume = 8 | issue = 1 | page = 10056 | date = 2018 | pmid = | doi = 10.1038/s41598-018-28477-9 }}</ref> | ||
| last10 | <ref name="Peterson, 2015">{{Citation | last1 = Peterson | first1 = D | author-link1 = Daniel Peterson | last2 =Brenu | first2 = EW | authorlink2 = Ekua Brenu | last3 = Gottschalk | first3 = G | author-link3 = Gunnar Gottschalk | last4 =Ramos | first4 = SB | author-link4 = Sandra Ramos | last5 = Nguyen | first5 = T | author-link5 = | last6 = Staines | first6 = D | author-link6 = Donald Staines | last7 =Marshall-Gradisnik | first7 = S | author-link8 = Sonya Marshall-Gradisnik | title = Cytokines in the Cerebrospinal Fluids of Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis | journal = Mediators of Inflammation | volume = 2015 | issue = | page = | date = 2015 | doi = 10.1155/2015/929720 }}</ref> | ||
| last11 | <ref name="Strayer,1995">{{Citation | last1 = Strayer | first1 = DR | author-link1 = David Strayer | last2 =Carter | first2 = W | authorlink2 = William Carter | last3 = Strauss | first3 = KI | author-link3 = Kenneth Strauss | last4 =Brodsky | first4 = I | author-link4 = | last5 = Suhadolnik | first5 = R | author-link5 =Robert Suhadolnik | last6 = Ablashi | first6 = D | author-link6 = Dharam Ablashi | last7 =Henry | first7 = B | author-link7 = | last8 = Mitchell | first8 = WM | author-link8 = William Mitchell | last9 = Bastien | first9 = S | author-link9 =Sheila Bastien | last10 = Peterson | first10 = D | author-link10 = Daniel Peterson | title = Long Term Improvements in Patients with Chronic Fatigue Syndrome Treated with Ampligen | journal = Journal of Chronic Fatigue Syndrome | volume = 1 | issue = 1 | page = 35-53 | date = 1995 | doi = 10.1300/J092v01n01_04 | url=| pages=|chapter=|edition=|isbn=}}</ref> | ||
| last12 | <ref name="Strayer, 2012">{{Citation | last1 = Strayer | first1 = DR | author-link1 = David Strayer | last2 =Carter | first2 = WA | authorlink2 = William Carter | last3 = Stouch | first3 = BC | author-link3 = | last4 = Stevens | first4 = SR | author-link4 = Staci Stevens | last5 = Bateman | first5 = L | author-link5 = Lucinda Bateman | last6 = Cimoch | first6 = PJ | author-link6 = | last7 =Lapp | first7 = CW | author-link8 =Charles Lapp | last8 = Peterson | first8 = DL | author-link8 = Daniel Peterson | last9 = Chronic Fatigue Syndrome AMP-516 Study Group | author-link9 = | last10 = Mitchell | first10 = WM | author-link10 = William Mitchell | title = A double-blind, placebo-controlled, randomized, clinical trial of the TLR-3 agonist rintatolimod in severe cases of chronic fatigue syndrome. | journal = PLoS One | volume = 7 | issue = 3 | page = e31334 | date = 2012 | pmid = 22431963 | doi = 10.1371/journal.pone.0031334 }}</ref> | ||
| last13 | <ref name="Unger, 2017">{{Citation | last1 = Unger | first1 = Elizabeth R. | author-link1 = Elizabeth Unger | last2 =Lin | first2 = Jin-Mann S. | authorlink2 = Jin-Mann Sally Lin | last3 =Tian | first3 = Hao| author-link3 = | last4 =Natelson | first4 = Benjamin H | author-link4 = Benjamin Natelson | last5 = Lange | first5 = Gudrun | author-link5 = Gudrun Lange | last6 = Vu | first6 = Diana | author-link6 = | last7 =Blate | first7 = Michelle | author-link7 = | last8 = Klimas | first8 = Nancy G. | author-link8 = Nancy Klimas | last9 = Balbin | first9 = Elizabeth G. | author-link9 = Elizabeth Balbin | last10 = Bateman | first10 = Lucinda | author-link10 = Lucinda Bateman | last11 = Allen | first11 = Ali | author-link11 = | last12 = Lapp | first12 = Charles W. | author-link12 = Charles Lapp | last13 = Springs | first13 = Wendy | author-link13 = | last14 = Kogelnik | first14 = Andreas M. | author-link14 = Andreas Kogelnik | last15 = Phan | first15 = Catrina C. | author-link15 = | last16 = Danver | first16 = Joan | author-link16 = | last17 = Podell | first17 = Richard N. | author-link17 = Richard Podell | last18 = Fitzpatrick | first18 = Trisha | author-link18 = | last19 = Peterson | first19 = Daniel L. | author-link19 = Daniel Peterson | last20 = Gottschalk | first20 = C. Gunnar | authorlink20 = Gunnar Gottschalk | last21 = Rajeevan | first21 = Mangalathu S. | authorlink21 = Mangalathu Rajeevan | last22 = MCAM Study Group | title = Multi-Site Clinical Assessment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (MCAM): Design and Implementation of a Prospective/Retrospective Rolling Cohort Study. | journal = American Journal of Epidemiology | volume = 1-10 | issue = | page = | date = 2017 | pmid = | doi = 10.1093/aje/kwx029 }}</ref> | ||
| last14 | |||
| last15 | |||
| last16 | |||
| last17 | |||
| last18 | |||
| last19 | |||
| last20 | |||
| last21 | |||
| last22 | |||
| last23 | |||
| last24 | |||
| last25 | |||
| title | |||
| journal = mBio | |||
| date | |||
| pmid | |||
| doi | |||
}} | |||
</ref> | |||
<ref name="BatemanL, 2015">{{Citation | |||
| last1 | |||
| last2 | |||
| last3 | |||
| last4 | |||
| last5 | |||
| last6 | |||
| last7 | |||
| last8 | |||
| last9 | |||
| last10 | |||
| title | |||
| journal = Fatigue: Biomedicine, Health & Behavior | volume = 3 | |||
| date | |||
| pmid | |||
| doi | |||
}} | |||
</ref> | |||
<ref name="Buchwald, 1992">{{Citation | |||
| last1 | |||
| last2 | |||
| last3 | |||
| last4 | |||
| last5 | |||
| last6 | |||
| last7 | |||
| last8 | |||
| last9 | |||
| last10 | |||
| last11 | |||
| last12 | |||
| last13 | |||
| last14 | |||
| last15 | |||
| last16 | |||
| last17 | |||
| title | |||
| journal = Annals of Internal Medicine | |||
| date | |||
| pmid | |||
}} | |||
</ref> | |||
<ref name="Hornig, 2016">{{Citation | |||
| last1 | |||
| last2 | |||
| last3 | |||
| last4 | |||
| last5 | |||
| last6 | |||
| last7 | |||
| last8 | |||
| title | |||
| journal = Molecular Psychiatry | |||
| date | |||
| doi | |||
}} | |||
</ref> | |||
<ref name="Hornig, 2017">{{Citation | |||
| last1 | |||
| last2 | |||
| last3 | |||
| last4 | |||
| last5 | |||
| last6 | |||
| last7 | |||
| title | |||
| journal = Translational Psychiatry | |||
| date | |||
| doi | |||
}} | |||
</ref> | |||
<ref name="KlimasNG, 2015">{{Citation | |||
| last1 | |||
| last2 | |||
| last3 | |||
| last4 | |||
| last5 | |||
| last6 | |||
| last7 | |||
| last8 | |||
| last9 | |||
| last10 | |||
| last11 | |||
| last12 | |||
| last13 | |||
| last14 | |||
| last15 | |||
| last16 | |||
| title | |||
| journal = Fatigue: Biomedicine, Health & Behavior | |||
| date | |||
| pmid | |||
| doi | |||
}} | |||
</ref> | |||
<ref name="Levine, 1992">{{Citation | |||
| last1 | |||
| last2 | |||
| last3 | |||
| last4 | |||
| last5 | |||
| last6 | |||
| last7 | |||
| last8 | |||
| last9 | |||
| last10 | |||
| last11 | |||
| last12 | |||
| title | |||
| journal = Archives of Internal Medicine | |||
| date | |||
| pmid | |||
| doi | |||
}} | |||
</ref> | |||
<ref name="Levine, 2000">{{Citation | |||
| last1 | |||
| last2 | |||
| last3 | |||
| last4 | |||
| title | |||
| journal = Journal of Chronic Fatigue Syndrome | |||
| date | |||
| pmid | |||
| doi | |||
}} | |||
</ref> | |||
<ref name="Nagy-Szakal, 2017">{{Citation | |||
| last1 | |||
| last2 | |||
| last3 | |||
| last4 | |||
| last5 | |||
| last6 | |||
| last7 | |||
| last8 | |||
| last9 | |||
| last10 | |||
| last11 | |||
| last12 | |||
| last13 | |||
| last14 | |||
| last15 | |||
| last16 | |||
| title | |||
| journal = Microbiome | |||
| date | |||
| pmid | |||
| doi | |||
}} | |||
</ref> | |||
<ref name="Nagy-Szakal, 2018">{{Citation | |||
| last1 | |||
| last2 | |||
| last3 | |||
| last4 | |||
| last5 | |||
| last6 | |||
| last7 | |||
| last8 | |||
| last9 | |||
| last10 | |||
| last11 | |||
| last12 | |||
| last13 | |||
| last14 | |||
| last15 | |||
| last16 | |||
| last17 | |||
| title | |||
| journal = Scientific Reports | |||
| date | |||
| pmid | |||
| doi | |||
}} | |||
</ref> | |||
<ref name="Peterson, 2015">{{Citation | |||
| last1 | |||
| last2 | |||
| last3 | |||
| last4 | |||
| last5 | |||
| last6 | |||
| last7 | |||
| title | |||
| journal = Mediators of Inflammation | |||
| date | |||
| doi | |||
}} | |||
</ref> | |||
<ref name="Strayer,1995">{{Citation | |||
| last1 | |||
| last2 | |||
| last3 | |||
| last4 | |||
| last5 | |||
| last6 | |||
| last7 | |||
| last8 | |||
| last9 | |||
| last10 | |||
| title | |||
| journal = Journal of Chronic Fatigue Syndrome | |||
| date | |||
| doi | |||
|url=|pages=|chapter=|edition=|isbn=}} | |||
</ref> | |||
<ref name="Strayer, 2012">{{Citation | |||
| last1 | |||
| last2 | |||
| last3 | |||
| last4 | |||
| last5 | |||
| last6 | |||
| last7 | |||
| last8 | |||
| last9 | |||
| last10 | |||
| title | |||
| journal = PLoS One | |||
| date | |||
| pmid | |||
| doi | |||
}} | |||
</ref> | |||
<ref name="Unger, 2017">{{Citation | |||
| last1 | |||
| last2 | |||
| last3 | |||
| last4 | |||
| last5 | |||
| last6 | |||
| last7 | |||
| last8 | |||
| last9 | |||
| last10 | |||
| last11 | |||
| last12 | |||
| last13 | |||
| last14 | |||
| last15 | |||
| last16 | |||
| last17 | |||
| last18 | |||
| last19 | |||
| last20 | |||
| last21 | |||
| last22 | |||
| title | |||
| journal = American Journal of Epidemiology | |||
| date | |||
| pmid | |||
| doi | |||
}} | |||
</ref> | |||
</references> | </references> | ||
Latest revision as of 19:58, July 29, 2023
Daniel L. Peterson, MD, is a physician in Incline Village, Nevada specializing in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). He was at the epicenter of the 1984 Incline Village chronic fatigue syndrome outbreak[1] and continues to be a leader in treatment and research about ME/CFS, serving on Simmaron Research’s Scientific Advisory Board and the Faculty of Health Sciences and Medicine at Griffith University in Queensland, Australia.[2]
He helped establish the Whittemore Peterson Institute (WPI) which was renamed in 2016 the Nevada Center for Biomedical Research.[3] He left in 2010 to return to private practice at Sierra Internal Medicine, Incline Village, Nevada.[4] In 2019, he joined the scientific advisory board of the Open Medicine Foundation.[5]
Dr. Peterson was the first physician to use Ampligen, an immunomodulator made by AIM ImmunoTech (formerly Hemispherx Biopharma), in the treatment for ME/CFS, using it on Nancy Kaiser, a very severe patient.[6] He has participated in every Ampligen trial since, up to the AMP-511, open label, cost-recovery trial available today.[7]
Several documentaries about myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) have featured Dr. Peterson, including, I Remember Me and Forgotten Plague, and the news feature, Sick and Tired.
Awards[edit | edit source]
- 2003, Rudy Perpich Senior Lectureship Award, presented to a distinguished CFS/FM scientist, physician or healthcare worker awarded by IACFS/ME[8]
- 2007, Nelson Gantz Outstanding Clinician Award awarded to a physician who emulates Nelson Gantz's clinical acumen, his passion for medicine, and his empathy for persons with CFS/FM awarded by IACFS/ME[8]
Writing committees[edit | edit source]
- 2003, Canadian Consensus Criteria - Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Clinical Working Case Definition, Diagnostic and Treatment Protocols[9] (Full Text)
- 2015, IOM Committee on Diagnostic Criteria for ME/CFS - Dr Peterson was a reviewer for the 2015 report produced by the Institute of Medicine's Committee on Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.[10]
Notable studies[edit | edit source]
- 1992, A chronic illness characterized by fatigue, neurologic and immunologic disorders, and active human herpesvirus type 6 infection[11] (Abstract)
- 1992, Clinical, Epidemiologic, and Virologic Studies in Four Clusters of the Chronic Fatigue Syndrome[12] (Abstract - can request full article)
- 1995, Long Term Improvements in Patients with Chronic Fatigue Syndrome Treated with Ampligen[13] (Abstract)
- 1997, Editorial - Chronic Fatigue Syndrome and Disability[14] (Abstract)
- 2000, Chronic Fatigue Syndrome and Cancer[15] (Abstract)
- 2001, Neuromyasthenia and Chronic Fatigue Syndrome (CFS) in Northern Nevada/California: A Ten-Year Follow-Up of an Outbreak[16] (Abstract)
- 2003, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Clinical Working Case Definition, Diagnostic and Treatment Protocols[17] (Full Text)
- 2004, Clinical and Biochemical Characteristics Differentiating Chronic Fatigue Syndrome from Major Depression and Healthy Control Populations: Relation to Dysfunction in the RNase L Pathway[18] (Full Text)
- 2012, A Multicenter Blinded Analysis Indicates No Association between Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and either Xenotropic Murine Leukemia Virus-Related Virus or Polytropic Murine Leukemia Virus[19] (Abstract)
- 2012, A double-blind, placebo-controlled, randomized, clinical trial of the TLR-3 agonist rintatolimod in severe cases of chronic fatigue syndrome[20] (Full Text)
- 2014, No association found between the detection of either xenotropic murine leukemia virus-related virus or polytropic murine leukemia virus and chronic fatigue syndrome in a blinded, multi-site, prospective study by the establishment and use of the SolveCFS BioBank[21] (Full Text)
- 2015, Cytokines in the Cerebrospinal Fluids of Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis[22] (Full Text)
- 2015, Findings from a clinical and laboratory database developed for discovery of pathogenic mechanisms in myalgic encephalomyelitis/chronic fatigue syndrome[23] (Abstract)
- 2015, Chronic fatigue syndrome and co-morbid and consequent conditions: evidence from a multi-site clinical epidemiology study[24] (Abstract)
- 2015, Distinct plasma immune signatures in ME/CFS are present early in the course of illness[25] - (Full text)
- 2016, Cytokine network analysis of cerebrospinal fluid in myalgic encephalomyelitis/chronic fatigue syndrome[26] (Abstract)
- 2017, Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome[27] (Full Text)
- 2017, Multi-Site Clinical Assessment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (MCAM): Design and Implementation of a Prospective/Retrospective Rolling Cohort Study[28] (Full Text)
- 2017, Immune network analysis of cerebrospinal fluid in myalgic encephalomyelitis/chronic fatigue syndrome with atypical and classical presentations[29] (Full Text)
- 2018, Decreased Expression of TRPM3 and mAChRM3 in the Small Intestine in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis[30] (Full text)
- 2018, Insights into myalgic encephalomyelitis/chronic fatigue syndrome phenotypes through comprehensive metabolomics[31] (Full Text)
- 2020, Myalgic encephalomyelitis/chronic fatigue syndrome patients exhibit altered T cell metabolism and cytokine associations[32] - (Full text)
- 2021, Molecular evidence of autophagy impairment as serum level of ATG13 is elevated in patients with myalgic encephalomyelitis and chronic fatigue syndrome: two independent case-control studies[33] - (Pre-print, Full text)
- 2022, Elevated ATG13 in serum of patients with ME/CFS stimulates oxidative stress response in microglial cells via activation of receptor for advanced glycation end products (RAGE)[34] - (Abstract)
Talks and interviews[edit | edit source]
ME/CFS Alert[edit | edit source]
- 2012, Episode 26, ME/CFS Alert interview
- 2013, Episode 50, ME/CFS Alert interview
Invest in ME International ME Conference[edit | edit source]
- 2007, Speaker on Day 1 of the 2nd Invest in ME International ME Conference on Experiences of Research into ME/CFS: Past, Present, and Future - (Video)
- 2007, Speaker on Day 2 of the 2nd Invest in ME International ME Conference on Clinical Research - (Video)
- 2009, Speaker at the 4th Invest in ME International ME Conference on Treatment Regimes for the Most Severe Cases[35] DVD available
- 2012, Speaker at the 7th Invest in ME International ME Conference on Clinical Research Update 2012[36] DVD available
- 2013, Speaker at the 8th Invest in ME International ME Conference on Key Note Speech: The Mainstreaming of ME Research[37] DVD available
Other[edit | edit source]
- 1996, Primetime Live TV Show - Sick and Tired - Incline Village Outbreak[38]
- 2000 Documentary, I Remember Me, directed by Kim A. Snyder[39]
- 2011, Dr. med. Dan Peterson (Simmaron Research) - Diagnose und Behandlung von ME/CFS, Teil 2
- 2011, Dr. med. Dan Peterson (Simmaron Research) - Diagnose und Behandlung von ME/CFS, Teil 1
- 2012, Phoenix Rising - Dr Daniel Peterson (July 12)
- 2015, 2015 De osynliga -Seminarium om ME/CFS, Sweden 19 October
- 2017, Solve ME/CFS Initiative’s 2nd Annual Discovery Forum: Presentation by Dr. Dan Peterson
Online presence[edit | edit source]
See also[edit | edit source]
- Ampligen
- Sierra Internal Medicine
- 1984 Incline Village chronic fatigue syndrome outbreak
- Paul Cheney
- List of myalgic encephalomyelitis and chronic fatigue syndrome outbreaks
- Canadian Consensus Criteria
Learn more[edit | edit source]
- Wikipedia - Daniel Peterson (physician)
- 1990, Chronic Fatigue Syndrome
- 2019, A Town for People with Chronic Fatigue Syndrome - New Yorker - about Ampligen
References[edit | edit source]
- ↑ "Dr. Dan Peterson (Sierra Internal Medicine, Incline Village, Nevada) - Health Rising". Health Rising. Retrieved August 13, 2018.
- ↑ "Collaborators - Simmaron Research". Simmaron Research. Retrieved August 13, 2018.
- ↑ "About Us". Nevada Center for Biomedical Research. Retrieved April 13, 2022.
- ↑ "History of Changes for Study: NCT00215813 | Study of Ampligen in Chronic Fatigue Syndrome". ClinicalTrials.gov. April 8, 2010. Retrieved April 13, 2020.
- ↑ "Daniel L. Peterson, MD". Open Medicine Foundation. Retrieved April 1, 2019.
- ↑ "TREATING THE DISEASE, NOT THE SYMPTOMS: NCF'S RESEARCH MOVES CFIDS/ME ONE STEP CLOSER TO NEOPLASTIC DISEASE PROCESS". ncf-net.org. Retrieved August 13, 2018.
- ↑ "Ampligen in Chronic Fatigue Syndrome". ClinicalTrials.gov. Retrieved August 13, 2018.
- ↑ 8.0 8.1 "IACFS/ME Awardees". IACFS/ME. Retrieved April 23, 2020.
- ↑ Carruthers, Bruce M.; Jain, Anil Kumar; De Meirleir, Kenny L.; Peterson, Daniel L.; Klimas, Nancy G.; Lerner, A. Martin; Bested, Alison C.; Flor-Henry, Pierre; Joshi, Pradip; Powles, AC Peter; Sherkey, Jeffrey; van de Sande, Marjorie (January 2003). "Myalgic Encephalomyelitis/Chronic Fatigue Syndrome". Journal of Chronic Fatigue Syndrome. 11 (1): 7–115. doi:10.1300/j092v11n01_02. ISSN 1057-3321.
- ↑ Institute of Medicine (2015). Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness. Washington, DC: The National Academies Press. doi:10.17226/19012. ISBN 0309316898. PMID 25695122.
- ↑ Buchwald, Dedra; Cheney, Paul R.; Peterson, Daniel L.; Henry, Berch; Wormsley, Susan B.; Geiger, Ann; Ablashi, Dharam V.; Salahuddin, S. Zaki; Saxinger, Carl; Biddle, Royce; Kikinis, Ron; Jolesz, Ferenc A.; Folks, Thomas; Balachandran, N.; Peter, James B.; Gallo, Robert C.; Komaroff, Anthony L. (1992), "A chronic illness characterized by fatigue, neurologic and immunologic disorders, and active human herpesvirus type 6 infection", Annals of Internal Medicine, 116 (2): 103-113, PMID 1309285
- ↑ Levine, Paul H.; Jacobson, Steven; Pocinki, Alan G.; Cheney, Paul; Peterson, Daniel; Connelly, Roger R; Weil, R; Robinson, SM; Ablashi, Dharam V; Salahuddin, Sayeef Z; Pearson, GR; Hoover, R (1992), "Clinical, Epidemiologic, and Virologic Studies in Four Clusters of the Chronic Fatigue Syndrome", Archives of Internal Medicine, 152 (8): 1611-1616, doi:10.1001/archinte.1992.00400200049009
- ↑ Strayer, DR; Carter, W; Strauss, KI; Brodsky, I; Suhadolnik, R; Ablashi, D; Henry, B; Mitchell, WM; Bastien, S; Peterson, D (1995), "Long Term Improvements in Patients with Chronic Fatigue Syndrome Treated with Ampligen", Journal of Chronic Fatigue Syndrome, 1 (1): 35-53, doi:10.1300/J092v01n01_04
- ↑ Peterson, Daniel L. (January 1997). "Chronic Fatigue Syndrome and Disability". Journal of Chronic Fatigue Syndrome. 3 (4): 5–7. doi:10.1300/j092v03n04_02. ISSN 1057-3321.
- ↑ Levine, Paul H.; Pilkington, Deborah; Strickland, Paula; Peterson, Daniel (2000), "Chronic Fatigue Syndrome and Cancer", Journal of Chronic Fatigue Syndrome, 7 (1): 29-38, doi:10.1300/J092v07n01_04
- ↑ Strickland, Paula S.; Levine, Paul H.; Peterson, Daniel L.; O'Brien, Karen; Fears, Thomas (January 2001). "Neuromyasthenia and Chronic Fatigue Syndrome (CFS) in Northern Nevada/California". Journal of Chronic Fatigue Syndrome. 9 (3–4): 3–14. doi:10.1300/j092v09n03_02. ISSN 1057-3321.
- ↑ Carruthers, Bruce M.; Jain, Anil Kumar; De Meirleir, Kenny L.; Peterson, Daniel L.; Klimas, Nancy G.; Lerner, A. Martin; Bested, Alison C.; Flor-Henry, Pierre; Joshi, Pradip; Powles, AC Peter; Sherkey, Jeffrey; van de Sande, Marjorie (January 2003). "Myalgic Encephalomyelitis/Chronic Fatigue Syndrome". Journal of Chronic Fatigue Syndrome. 11 (1): 7–115. doi:10.1300/j092v11n01_02. ISSN 1057-3321.
- ↑ Suhadolnik, Robert J.; Peterson, Daniel L.; Reichenbach, Nancy L.; Roen, Gail; Metzger, Melodie; McCahan, John; O'Brien, Karen; Welsch, Suzanne; Gabriel, Jerome; Gaughan, John P.; McGregor, Neil R. (2004). "Clinical and Biochemical Characteristics Differentiating Chronic Fatigue Syndrome from Major Depression and Healthy Control Populations: Relation to Dysfunction in the RNase L Pathway". Journal of Chronic Fatigue Syndrome. 12 (1): 5–35. doi:10.1300/J092v12n01_02.
- ↑ Alter, Harvey J.; Mikovits, Judy A.; Switzer, William M.; Ruscetti, Francis W.; Lo, Shyh-Ching; Klimas, Nancy; Komaroff, Anthony L.; Montoya, Jose G.; Bateman, Lucinda; Levine, Susan; Peterson, Daniel; Levin, Bruce; Hanson, Maureen R.; Genfi, Afia; Bhat, Meera; Zheng, HaoQiang; Wang, Richard; Li, Bingjie; Hung, Guo-Chiuan; Lee, Li Ling; Sameroff, Stephen; Heneine, Walid; Coffin, John; Hornig, Mady; Lipkin, W. Ian (2012), "A Multicenter Blinded Analysis Indicates No Association between Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and either Xenotropic Murine Leukemia Virus-Related Virus or Polytropic Murine Leukemia Virus", mBio, 3 (5): e00266–12, doi:10.1128/mBio.00266-12
- ↑ Strayer, DR; Carter, WA; Stouch, BC; Stevens, SR; Bateman, L; Cimoch, PJ; Lapp, CW; Peterson, DL; Chronic Fatigue Syndrome AMP-516 Study Group; Mitchell, WM (2012), "A double-blind, placebo-controlled, randomized, clinical trial of the TLR-3 agonist rintatolimod in severe cases of chronic fatigue syndrome.", PLoS One, 7 (3): e31334, doi:10.1371/journal.pone.0031334, PMID 22431963
- ↑ Irlbeck, David M.; Vernon, Suzanne D.; McCleary, K. Kimberly; Bateman, Lucinda; Klimas, Nancy G.; Lapp, Charles W.; Peterson, Daniel L.; Brown, James R.; Remlinger, Katja S.; Wilfret, David A.; Gerondelis, Peter (2014). "No association found between the detection of either xenotropic murine leukemia virus-related virus or polytropic murine leukemia virus and chronic fatigue syndrome in a blinded, multi-site, prospective study by the establishment and use of the SolveCFS BioBank". BMC Research Notes. 7: 461. doi:10.1186/1756-0500-7-461.
- ↑ Peterson, D; Brenu, EW; Gottschalk, G; Ramos, SB; Nguyen, T; Staines, D; Marshall-Gradisnik, S (2015), "Cytokines in the Cerebrospinal Fluids of Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis", Mediators of Inflammation, 2015, doi:10.1155/2015/929720
- ↑ Klimas, N.G.; Ironson, G.; Carter, A.; Balbin, E.; Bateman, L.; Felsenstein, D.; Levine, S.; Peterson, D.; Chiu, K.; Allen, A.; Cunningham, K.; Gottschalk, C.G.; Fletcher, M; Hornig, M.; Canning, C.; Komaroff, A.L. (2015), "Findings from a clinical and laboratory database developed for discovery of pathogenic mechanisms in myalgic encephalomyelitis/chronic fatigue syndrome", Fatigue: Biomedicine, Health & Behavior, 3 (2): 75-96, doi:10.1080/21641846.2015.1023652
- ↑ Bateman, L.; Darakjy, S.; Klimas, N.; Peterson, D.; Levine, S.M.; Allen, A.; Carlson, S.A.; Balbin, E.G.; Gottschalk, G.; March, D. (2015), "Chronic fatigue syndrome and co-morbid and consequent conditions: evidence from a multi-site clinical epidemiology study", Fatigue: Biomedicine, Health & Behavior, 3 (1): 1-15, doi:10.1080/21641846.2014.978109
- ↑ Hornig, M; Montoya, JG; Klimas, NG; Levine, SM; Felsenstein, D; Bateman, L; Peterson, DL; Gottschalk, CG; Schultz, AF; Che, X; Eddy, ML; Komaroff, AL; Lipkin, WI (2015). "Distinct plasma immune signatures in ME/CFS are present early in the course of illness". Science Advances. 1 (1). doi:10.1126/sciadv.1400121.
- ↑ Hornig, M; Gottschalk, G; Peterson, D; Knox, KK; Schultz, AF; Eddy, ML; Che, X; Lipkin, WI (2016), "Cytokine network analysis of cerebrospinal fluid in myalgic encephalomyelitis/chronic fatigue syndrome.", Molecular Psychiatry, 21 (2): 261-9, doi:10.1038/mp.2015.29
- ↑ Nagy-Szakal, Dorottya; Williams, Brent L.; Mishra, Nischay; Che, Xiaoyu; Lee, Bohyun; Bateman, Lucinda; Klimas, Nancy G.; Komaroff, Anthony L.; Levine, Susan; Montoya, Jose G.; Peterson, Daniel L.; Ramanan, Devi; Jain, Komal; Eddy, Meredith L.; Hornig, Mady; Lipkin, W. Ian (2017), "Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome", Microbiome, 5 (44), doi:10.1186/s40168-017-0261-y
- ↑ Unger, Elizabeth R.; Lin, Jin-Mann S.; Tian, Hao; Natelson, Benjamin H; Lange, Gudrun; Vu, Diana; Blate, Michelle; Klimas, Nancy G.; Balbin, Elizabeth G.; Bateman, Lucinda; Allen, Ali; Lapp, Charles W.; Springs, Wendy; Kogelnik, Andreas M.; Phan, Catrina C.; Danver, Joan; Podell, Richard N.; Fitzpatrick, Trisha; Peterson, Daniel L.; Gottschalk, C. Gunnar; Rajeevan, Mangalathu S.; MCAM Study Group (2017), "Multi-Site Clinical Assessment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (MCAM): Design and Implementation of a Prospective/Retrospective Rolling Cohort Study.", American Journal of Epidemiology, 1–10, doi:10.1093/aje/kwx029
- ↑ Hornig, M; Gottschalk, G; Eddy, ML; Che, X; Ukaigwe, JE; Peterson, DL; Lipkin, WI (2017), "Immune network analysis of cerebrospinal fluid in myalgic encephalomyelitis/chronic fatigue syndrome with atypical and classical presentations", Translational Psychiatry, 7 (4), doi:10.1038/tp.2017.44
- ↑ Marshall-Gradisnik, Sonya; Fretel, Marshall; Eaton, Natalie; Cabanas, Helene; Balinas, Cassandra; Gopalan, Vinod; Petersen, Daniel; Passmore, Rachel; Tang, Kevin; Haque, Mazhar; Lam, Alfred; Staines, Donald (May 31, 2018). "Decreased Expression of TRPM3 and mAChRM3 in the Small Intestine in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis". International Journal of Clinical Medicine. 09 (05): 467. doi:10.4236/ijcm.2018.95040.
- ↑ Nagy-Szakal, Dorottya; Barupal, Dinesh K.; Lee, Bohyun; Che, Xiaoyu; Williams, Brent L.; Kahn, Ellie J.R.; Ukaigwe, Joy E.; Bateman, Lucinda; Klimas, Nancy G.; Komaroff, Anthony L.; Levine, Susan; Montoya, Jose G.; Peterson, Daniel L.; Levin, Bruce; Hornig, Mady; Fiehn, Oliver; Lipkin, W. Ian (2018), "Insights into myalgic encephalomyelitis/chronic fatigue syndrome phenotypes through comprehensive metabolomics", Scientific Reports, 8 (1): 10056, doi:10.1038/s41598-018-28477-9
- ↑ Mandarano, Alexandra H.; Maya, Jessica; Giloteaux, Ludovic; Peterson, Daniel L.; Maynard, Marco; Gottschalk, C. Gunnar; Hanson, Maureen R.; Maureen Hanson (February 10, 2020). "Myalgic encephalomyelitis/chronic fatigue syndrome patients exhibit altered T cell metabolism and cytokine associations". Journal of Clinical Investigation. 130 (3): 1491–1505. doi:10.1172/jci132185.
- ↑ Avik, R; Gottschalk, Carl G; Peterson, Daniel; Knox, K; Maynard, M; Whelan, RJ (September 29, 2021). "Molecular evidence of autophagy impairment as serum level of ATG13 is elevated in patients with myalgic encephalomyelitis and chronic fatigue syndrome: two independent case-control studies". Researchsquare. doi:10.21203/rs.3.rs-925403/v1. Retrieved November 5, 2022.
- ↑ Gottschalk, Carl G; Peterson, Daniel; Knox, Konstance; Maynard, Marco; Whelan, Ryan J.; Roy, Avik (May 1, 2022). "Elevated ATG13 in serum of patients with ME/CFS stimulates oxidative stress response in microglial cells via activation of receptor for advanced glycation end products (RAGE)". Molecular and Cellular Neuroscience. 120: 103731. doi:10.1016/j.mcn.2022.103731. ISSN 1044-7431.
- ↑ "IIMEC4". Invest in ME Research. Retrieved February 4, 2020.
- ↑ "IIMEC7 International ME Conference 2012". Invest in ME Research. Retrieved February 4, 2020.
- ↑ "IIMEC8 International ME Conference 2013". Invest in ME Research. Retrieved February 4, 2020.
- ↑ CFS and the CDC's Failure to Respond: Primetime Live (1996), retrieved February 4, 2020
- ↑ I Remember Me, retrieved February 4, 2020
